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Abstract: A fluorometric method, based on the fluorescence properties of the 
aluminium(III)–hesperidin complex, for the determination of hesperidin in hu-
man plasma and pharmaceutical forms has been developed and validated. The 
complex shows a strong emission in the presence of the surfactant betain sul-
phonate SB 12 at 476 nm with excitation at 390 nm. The linearity range for 
pharmaceutical forms of hesperidin was 0.06–24.4 μg mL-1 with a limit of 
detection, LOD, of 0.016 μg mL-1 and a limit of quantification, LOQ, of 0.049 
μg mL-1. Recovery values in the range 99.3–99.7 % indicate good accuracy of 
the method. A linear dependence of the intensity of fluorescence of the com-
plex on the concentration of hesperidin in plasma was obtained in concentra-
tion range from 0.1–12.2 μg mL-1. The LOD was 0.032 μg mL-1 while LOQ 
was 0.096 μg mL-1. Recovery values were in the range 98.4–99.8 %. The re-
liability of the method was checked by an LC–MS/MS method for plasma 
samples and an HPLC/UV method for tablets with direct determination of hes-
peridin after separation. Linearity range in determination of hesperidin in phar-
maceutical forms was obtained in the range from 0.05 to 10.00 μg mL-1. The 
LOD was 0.01 μg mL-1 and the LOQ was 0.03 μg mL-1. The linearity range for 
the determination of hesperidin in plasma was 0.02–10.00 μg mL-1 with an 
LOD 0.005 μg mL-1 and an LOQ of 0.015 μg mL-1. The good agreement 
between the two methods indicates the usability of the proposed fluorometric 
method for the simple, precise and accurate determination of hesperidin in cli-
nical and quality control laboratories. 
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INTRODUCTION 
Flavonoids constitute a large group of naturally occurring phenolic com-
pounds distributed in the plant kingdom. They are regularly consumed as food 
(e.g., vegetables and fruits) and beverages such as tea and red wine. According to 
their chemical structure, they are usually subdivided into flavanols, anthocya-
nidins, flavones, flavanones and chalcones. These different flavonoids are re-
ported to possess a wide range of biological activities, including anti-inflamma-
tory, anti-oxidant, anti-allergic, hepatoprotective, anti-thrombotic, anti-viral, car-
diovascular and anti-carcinogenic effects.1  
Flavonoids are also effective metal ion chelators and form stable products 
that in several cases are highly fluorescent, a property which has been used in 
analytical methods for metal and ligand identification.2,3 It is well known that 
they can chelate metallic ions such as beryllium (II),4 aluminium(III),5 iron(III),6 
and zinc(II) ion.7 These complexes shown intense fluorescence signal which in-




thyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one (Scheme 1), 
is a flavanone-type flavonoid that is abundant in citrus fruit8 and has been re-
ported to exert a wide range of pharmacological effects.9 
 
Scheme 1. The molecular structure of hesperidin. 
Hesperidin has also been reported to possess anti-inflammatory, anti-aller-
genic, antihypertensive, antimicrobial, and vasodilatory properties and to de-
crease bone density loss.10–12 Taking into account the biological effects of hes-
peridin, it is of interest to develop simple, accurate and precise methods for its 
determination in human plasma and pharmaceutical forms. 
Various methods have been developed for the determination of hesperidin, 
such as high-performance liquid chromatography with UV/Vis and electroche-
mical detection modes,13,14 liquid chromatography/mass spectrometry (LC–MS),15 
radio-immunoassey,16 adsorptive-stripping voltammetry,17 cathodic-stripping vol-
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tammetry,18 spectrophotometry,19,20 spectrofluorometry with manual and flow 
injection methods21 and pulse perturbation of an oscillatory reaction system.22 
Perez-Ruiz et al.21 developed and validated a spectrofluorimetrc method for 
the determination of hesperidin in orange peel and orange juice based on com-
plexation between hesperidin and the aluminium(III)-ion in a micellar (sodium 
dodecylsulphate) medium. Manual and flow injection procedures were used for 
samples introduction using an excitation wavelength of 391 nm and an emission 
wavelength of 496 nm. The linear concentration range for hesperidin was 
between 5×10–7 to 2×10–5 mol L–1, with a detection limit of 79 μg L–1.  
In this work, the same basic chemistry of the fluorescence reaction between 
aluminium (III)-ion and hesperidin for the determination of hesperidin in human 
plasma and pharmaceutical forms was employed. The zwiterionic surfactant sul-
phobetaine SB 12 (3-(N-hexadecyl-N,N-dimethylammonio)propane sulphonate) 
was used for fluorescence enhancement with an excitation wavelength of 390 nm 
and an emission wavelength at 476 nm. As comparative methods, an LC-MS/MS 
determination of hesperidin in human plasma and an HPLC/UV method for its 
determination in some pharmaceutical formulations were used. 
EXPERIMENTAL 
Materials and solutions 
Aluminium nitrate, hesperidin (C28H34O15; Mr = 610.56 g mol-1; CAS number 520-26-3) 
(Fluka AG), methanol, NaOH, CH3COOH (Merck), all p.a. grade, were used. SB 12 or (n-
dodecyl sulphobetaine) (Serva, Germany) and sodium dodecylsuphate (SDS, Sigma Aldrich) 
were used. All reagents were employed without further purification. A stock solution of alu-
minium nitrate was prepared by dissolving Al(NO3)3 in doubly distilled water with the addi-
tion of an appropriate amount of nitric acid to prevent the initial hydrolysis of the alum-
inium(III) ion. The content of Al(III) ions was determined gravimetrically by precipitation 
with ammonia. A solution of hesperidin was prepared by dissolving a precisely measured 
mass of hesperidin in 70 vol. % methanol. A solution of SB 12 (0.5 mol L-1) was prepared by 
dissolving a precisely measured mass of SB 12 in deionised water. A solution of SDS (0.5 mol 
L-1) was prepared by dissolving a precisely measured mass of SDS in deionised water. These 
solutions were stored in a refrigerator. 
Human pool plasma was obtained from the Department of Transfusion of the Clinical 
Hospital “Dr Dragiša Mišović”, Belgrade, Serbia. Helopyrin tablets (nominal composition 
vitamin C 120 mg, bioflavonoids 20 mg, rutin 15 mg, excipients: microcrystalline cellulose, 
methylhydroxypropyl cellulose, Mg-stearate, starch hydrolysate) were from Rosch & Handel, 
(Vienna, Austria) and Vitamin C 1500 tablets with hesperidin were from American Nutrition 
Products.  
Working solutions were prepared by dilution of stock solution and aluminium nitrate 
(1.00×10-3 mol L-1 Al(NO3)3) and hesperidin (1.00×10-4 mol L-1). 
Instruments 
The fluorescence spectra were collected using a Fluorolog-3 spectrofluorimeter (Jobin 
Yvon Horiba, Paris, France) equipped with a 450 W xenon lamp and a photomultiplier tube. 
The samples were placed in a 1 cm optical path length quartz cuvette for spectral recording. 
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The slits on the excitation and emission beams were both set at 5 nm. The spectra were cor-
rected for the dark counts. In each measurement, three scans with a one-second-integration 
time were averaged. The emission spectrum of the solvent (70 vol. % methanol) was sub-
tracted. All measurements were performed at 25 °C controlled by a Peltier element. The pH 
measurements of were realised using a Metler Toledo mp 120 pH-meter (precision: ±0.01 pH 
unit) equipped with a combined glass electrode. All spectrofluorometric measurements were 
made in acetate buffers at pH 4.58 (in 70 vol. % methanol) which was prepared according to 
Perrin.23 
Chromatographic measurements were carried out using the HPLC system Perkin Elmer 
PE200 (Norwalk, CT, USA), composed of a binary pump, an autosampler (injection volume 
20 µL) and equipped with a Gemini C18 column (150×4.6 mm, 3 µm, Phenomenex, CA, 
USA), a column thermostat and variable UV–Vis detector operating at 280 nm. The experi-
mental conditions were as follows: mobile phase A: 2% acetic acid; mobile phase B: aceto-
nitrile, mixed in a linear gradient, 0–5 min: 85 % A, 15 % B; 25–30 min: 10 % A, 90 % B; 
35–40 min: 85 % A, 15 % B; flow rate: 0.7 mL min-1; injection volume: 20 µL. 
Mass spectrometric conditions 
A 3200 QTRAP MS/MS mass spectrometer (Applied Biosystems/MDS Sciex, Foster 
City, CA, USA) with ESI ionisation (ESI and turbo-ion spray, TIS) was employed. The data 
were processed using Analyst TM software (PE Sciex). The negative ionization mode of the 
LC–MS/MS was used for monitoring selected multiple reaction (SRM) analyses with a dwell 
time 50 ms. The mass spectrometric parameters were optimized to maximize the SRM sen-
sitivity by injecting a 100 µg mL-1 standard solution of hesperidin in methanol using a sy-
ringe. The optimized instrument conditions were as follows: interface temperature, 500 °C; 
ion spray voltage, 4500 V; curtain gas He at 10 psi; nebulizing gas N2 at 40 psi; TIS gas He at 
60 psi; declustering potential (DP), 57 V; entrance potential (EP), –5 V; collision energy (CE) 
–34 eV and collision cell exit potential (CXP), 9 V. The signal used to detect and quantify 
hesperidin was SRM transition at m/z 609 → 325. The mass spectrometer was operated at unit 
mass resolution for both the Q1 and Q3 quadrupoles. 
RESULTS AND DISCUSSION 
Complex formation between hesperidin and aluminium(III)-ion 
Hesperidin and aluminium(III) ions upon reaction in methanolic solution 
form a complex in the pH range 3.0–7.0. The stoichiometry of the complex was 
estimated by the Job method24 and by the mole ratio method.25  
The reaction of hesperidin and aluminium(III) ions in methanolic solution in 
the pH range 3.0–7.0 leads to the formation of a complex, as evidenced by the 
large increase of fluorescence intensity (order of magnitude 105) and bathochro-
mic shift (ca. 50 nm) of the emission band of hesperidin in the presence of alu-
minium(III) ions. The fluorescence spectra were recorded using 70 % v/v me-
thanol as a blank. The excitation spectra were followed at λem = 490 nm and the 
excitation wavelength used for recording the emission spectra was λex = 390 nm. 
The excitation (1′) and emission (1) spectra of the aluminium(III)–hesperidin 
solution and the excitation (2′) and emission (2) spectra of hesperidin are shown 
in Fig. 1. 
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Fig. 1. Exitation (1′) and emission (1) spectra of the aluminium (III)–hesperidin complex and 
exitation (2′) and emission (2) spectra of hesperidin. 
As indicated by the Job24 method, the most probable stoichiometry of the 
complex formed at pH 4.58 is aluminium:hesperidin = 1:1. The mole ratio me-
thod25 for the determination of the composition of the aluminium(III)–hesperidin 
complex formed at pH 4.58 confirmed the 1:1 ratio for the complex (Fig. 2). 
Thus, the complexation equilibrium is not stepwise and the complex is 
formed in a single step. 
The stability constant of the complex at pH 4.58 was estimated from the Job 
plot and the (conditional) stability constant was found to be log K = 8.26±0.02.  
The formation of a stable aluminium (III)–hesperidin complex in methanolic 
solution in presence of SB 12 with enhanced fluorescence could be utilized for 
the quantitative determination of hesperidin in various matrices in trace amounts. 
It was decided to develop and validate a method for the determination of hes-
peridin in human serum and pharmaceutical dosages forms. 
Method development 
The critical parameters for the development of a fluorometric method in-
volved the composition of the solvent, the concentration of aluminium, the con-
centration of SB 12, pH and the reaction time between aluminium(III) ion and 
hesperidin. The optimal values for these parameters were determined in order to 
attain the maximum fluorescence intensity. 
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Fig. 2. Method of mole ratios. Dependence of intensity of fluorescence 
on ratio chesp/cAl(III). 
The composition of the solvent influences the fluorescence intensity and the 
solubility of the complex. Solvent compositions examined were 30, 50, 70 and 90 
vol. % of methanol. The optimal composition of the solvent was methanol:water 
70:30 v/v because in this solvent, the maximum intensity of the fluorescence and 
solubility of the complex was observed.  
Concentration of aluminium(III) ions also influences the intensity of fluores-
cence and for this optimisation, different concentrations of aluminium(III) ions in 
the range 1×10–6–5×10–5 mol L–1 (cAl:cL = 1:1 to 50:1, pH 4.0) were examined. 
The fluorescence intensity increased with increasing concentration of alumi-
nium(III) ion up to 5×10–5 mol L–1. 
Influence of pH on the fluorescence intensity of the aluminium(III)–hespe-
ridin complex was examined in the range 3.0–7.0, as shown in Fig. 3. The pH 
dependence of fluorescence intensity exhibited a complex shape. At low pH va-
lues, the intensity decreased because protons tended to displace aluminium(III) 
ion. At pH values higher than 4.58, the intensity again decreased because more of 
the aluminium(III) ions were in the form of hydroxide complexes. The optimal 
pH value was around 4.5, which was used for all further experiments.  
According to the work Peres-Ruiz et al.,21 the type of surfactant has a great 
influence on the fluorescence intensity. They studied the influence of cationic, 
anionic and non-ionic surfactants on fluorescence intensity, but did not examine 
the influence of zwiterionic micellar media For this reason, the surfactant SB 12 
was used in the present study. The concentration of surfactant was about three 
times that of the critical micellar concentration and it was shown that this surf-
actant increase the fluorescence intensity by` about 5 times compared to metha-
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nolic solution with no addition of SB 12. With purpose of investigating the in-
fluence of surfactants on the fluorescence intensity of the aluminium(III)–hespe-
ridin complex, the emission spectra of aluminium(III)–hesperidin complex without 
surfactants (Fig. 4, curve 1), and in presence of SDS (Fig. 4, curve 2), and SB 12 
(Fig. 4, curve 3) were recorded. Based on the obtained results (Fig. 4), the sig-
nificant influence of SB 12 on the fluorescence intensity was confirmed. 
Fig. 3. Effect of pH on the in-




Fig. 4. Influence of surfactants on the intensity of the fluorescence of the aluminium(III)– 
–hesperidin complex: emission spectra of the aluminium(III)–hesperidin complex without 
surfactants (1), emission spectra of complex in presence of SDS (2) and SB 12 (3). 
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For the study of the effect of the micelar medium (SB 12) on the excitation 
and emission spectra of the aluminium(III)–hesperidin complex in 70 % metha-
nol was studied. The zwitterionic surfactant, SB 12 was tested at a concentration 
of about three times that of the critical micellar concentration. The fluorescence 
emission spectra shown in Fig. 5 were recorded in 70 vol. % methanol using an 
excitation wavelength of λex= 390 nm. The emission spectra of the alumi-
nium(III)–hesperidin complex (1) and of hesperidin (1′) are illustrated in Fig. 5a, 




Fig. 5. a) Emission spectra of the 
aluminium(III)–hesperidin complex 
(1) and hesperidin(1′); b) emission 
spectra of the aluminium(III)–hespe-
ridin complex (2) and hesperidin (2′), 
both in the presence of SB 12. 
From Fig. 5, it could be seen that the wavelength of the emission maxima 
were hypsochromically shifted to λem= 476 nm and the intensity of the complex 
fluorescence increased by about four times in presence of SB 12. Due to this, all 
measurements were performed in the presence of SB 12 at this concentration. 
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Fluoromeric analysis of hesperidin in pharmaceutical preparations 
The calibration curve method was used, requiring solutions containing constant 
concentrations of SB 12 and Al(NO3)3 and different concentrations of hesperidin 
in acetate buffer (using 70 vol. % methanol as the solvent) at pH 4.58. The blank 
was acetate buffer of pH 4.58.  
The regression equation: 
 IF = (4.06 ± 0.01)c + (1.27 ± 0.02) (1) 
(N = 9) was calculated with the aid of Origin, version 7, software, where IF is 
fluorescence intensity in % (λem = 476 nm) and c is concentration of hesperidin 
in μg mL–1. The good linearity of the calibration curve and the negligible scatter 
of experimental points are confirmed by the high correlation coefficient, r = 
= 0.99999. Linear dependence of the intensity of fluorescence of the complex 
was obtained in concentration range from 0.06–22.4 μg mL–1. 
LOD (limit of detection) and LOQ (limit of quantification). The limit of de-
tection (LOD)26,27 was calculated by establishing the minimum level at which 
hesperidin can be detected, according to the formula: 
 b3.3sLOD
a
=  (2) 
where sb is the standard deviation of the intercept and a is the slope of the ca-
libration line. It was found that the LOD is 0.016 μg mL–1. 
The limit of quantification (LOQ)26,27 was determined by using the formula: 
 b10sLOQ
a
=  (3) 
Thus, hesperidin can be quantified at a concentration of 0.049 μg mL–1. 
Precision. The accuracy of the method was determined for four different 
hesperidin concentrations (Table I). The accuracy and repeatability of the method 
is fairly high as indicated by good recovery and low values of the SD. 
TABLE I. The fluorimetric determination of hesperidin in aqueous–methanolic solutions (N = 5) 
Added, μg mL-1 Found, μg mL-1 Recovery, % SD×103 CV / % 
0.305 0.303 99.3 2.45 0.81 
0.611 0.609 99.7 1.71 0.28 
1.222 1.218 99.7 2.92 0.24 
6.110 6.085 99.6 7.8 0.13 
The results of the obtained analysis are given in Table II. 
Procedure for analysis of hesperidin in pharmaceutical preparations 
Hesperidin in pharmaceutical forms was analysed by the proposed method. 
For the analyses of hesperidin in helopyrin tablets, ten tablets were weighed and 
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powdered using a pestle and mortar. A portion of the powder, equivalent to 
weight of one tablet, was dissolved in 100 ml 70 vol. % v/v of methanol and the 
solution was filtered through a Millipore membrane filter with pore size 0.45 μm. 
0.25 mL of this solution, 0.35 mL of 0.5 mol L-1 SB 12 and 0.5 mL of 1×10–3 
mol L–1 Al(NO3)3 were mixed in a 10-mL volumetric flask and diluted to the 
mark with acetate buffer of pH 4.58 (in 70 % v/v methanol). The fluorescence of 
the prepared solution was taken at λex = 390 nm and λem = 476 nm. The blank 
was acetate buffer of pH 4.58. 
TABLE II. The fluorimetric determination of hesperidin in pharmaceutical preparations 
Tablets Found, mg Recovery, % SD / % CV / % 
Helopyrin, declared 20 mg bioflavonoids 18.06 90.3 0.12 0.66 
Vitamin C, content of hesperidin not declared 117.38 – 0.81 0.69 
The method suitability was confirmed by taking the fluorescence spectra of 
the excipient mix (microcrystalline cellulose, methylhydroxypropyl cellulose, 
Mg-stearate and starch hydrolysate) with the addition of 0.5 mL 1.0×10–3 mol L–1 
of Al(NO3)3 solution. In Fig. 6 the spectra of aluminium(III) ions + tablet solu-
tion and aluminium(III) ion + excipient mix are shown, from which it may be 
seen that excipients did not interfere with hesperidin determination. Under the 
chosen experimental conditions, the aluminium complex with rutin (and other 
citrus flavonoids in the tablets) did not produce measurable fluorescence, and 
thus, rutin does not interfere with the hesperidin determination. 
 
Fig. 6. Emission spectra of the aluminium–hesperidin complex in helopyrin tablets (1) 
and excipient mix (2). The blank was acetate buffer at pH 4.58. 
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The content of hesperidin in helopyrin tablets is in good agreement with con-
tent that Obendorf et al. obtained using the cathodic stripping voltammetry me-
thod.18 
Determination of hesperidin in plasma 
0.2 mL human pool plasma, 0.35 mL of 0.5 mol L–1 SB 12 and different 
volumes of hesperidin stock solution to give concentrations of 0.1–12.2 μg mL–1 
were mixed in a 10-mL volumetric flask and diluted to the mark with pH 4.58 
acetate buffer (in 70 vol. % methanol). After incubation (30 min), 0.5 mL of 
1×10–3 mol L–1 Al(NO3)3 was added. The fluorescence of the prepared solutions 
were measured at λex = 390 nm and λem = 476 nm. Plasma with SB 12 in acetate 
buffer (pH 4.58) served as the blank. 
Linear dependence of the intensity of fluorescence of the complex on the 
concentration of hesperidin in diluted plasma samples was obtained in the inter-
val 0.1–12.2 μg mL–1. The regression equation was calculated (IF is fluorescence 
intensity in %, and c is the concentration of hesperidin in μg mL–1): 
 IF = (4.12 ± 0.02)c + (2.13 ± 0.04) (4) 
 (N = 7, r = 0.99998).  
The LOD of hesperidin in plasma was calculated to be 0.032 μg mL–1. The 
LOQ of hesperidin in plasma showed that it could be quantified at a concen-
tration of 0.096 μg mL–1.  
Three different concentrations of hesperidin were added to human plasma in 
order to obtain concentrations of hesperidin in plasma in the range 0.122–6.110 
μg mL–1. These plasma samples were treated in the same way as for the calib-
ration graph. The analytical recovery was 98.4–99.8 %. The low values of rela-
tive error (RE) and the relative standard deviation of determination (RSD) indi-
cate very good reproducibility of the measurements. The results are given in 
Table III. 
TABLE III. The fluorimetric determination of hesperidin in serum samples (N = 5) 
Added, μg mL-1 Found, μg mL-1 Recovery, % SD×103 CV / % 
0.122 0.120 98.4 1.08 0.86 
0.611 0.610 99. 8 1.22 0.20 
6.110 6.091 99.7 1.30 0.21 
HPLC and mass spectrometric determination of hesperidin 
Preparation of solutions for HPLC and mass spectrometric determination of 
hesperidin. A stock solution of hesperidin (1.0226 mg mL–1) was prepared in 
methanol. A series of working standard solutions of hesperidin in the concen-
tration range: 0.02–12.2 μg mL–1 was prepared by diluting the stock solution 
with methanol. 
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Solid phase extraction of plasma samples 
Hesperidin was extracted from the plasma samples using LC-18 (500 mg) 
Supelco cartridges. The cartridges were preconditioned with 5 mL of methanol 
followed by 5 mL of Milli-Q water. Then 5 mL of sample was forced through the 
cartridge at a flow rate of about 0.5 mL min–1. After loading, the SPE cartridge 
was washed with 5 mL of Milli-Q water and then dried under vacuum for 10 min. 
Finally, the sample was eluted with 2.5 mL of methanol. Human plasma samples 
were thermostated at 25 °C and after fortification with hesperidin were subjected 
to protein precipitation and liquid–liquid extraction. To a tube containing 1.0 mL 
of plasma was added 500 μL methanol or a standard solution of hesperidin. 
2-Propanol (1.0 mL) was added to precipitate the proteins. The mixture was then 
vortex-mixed for 1 min and centrifuged at 10000×g for 10 min. The upper clear 
solution layer was collected and 500 μL water and 500 μL saturated solution of 
potassium chloride were added. After mixing for 15 s, 5 mL ethyl acetate was ad-
ded and the sample was vortex-mixed for 1 min and shaken for 10 min. After 
centrifugation at 3500×g for 5 min, the upper organic layer was transferred to 
another tube and evaporated under nitrogen at 40 °C. The residue was recon-
stituted in 1 mL methanol and 20 μL was injected into the HPLC and MS sys-
tem.28 The extract was first injected onto a Gemini column in the HPLC/UV 
system with gradient elution and UV detection. The obtained results confirmed 
the presence of only hesperidin without interfering substances in the extract. The 
quantification was subsequently performed by injection of 20 μL of the extract 
into the MS system using the autosampler of the HPLC system but bypassing the 
chromatographic column. 
To check the reliability of fluorescence method the direct HPLC determi-
nation of hesperidin in plasma samples LC–MS/MS and HPLC/UV methods in 
tablets, were developed as modifications of reported methods.29 Two calibration 
curves were established for the determination of hesperidin: in methanol medium 
and in plasma spiked with known quantities of hesperidin. 
Analysis of tablets 
The helopyrin tablets were analysed for their hesperidin content. The tablets 
were prepared for analysis according to the procedure given for the fluorometric 
determination. No extraction procedure was used. Different aliquots of the tablet 
solutions were subjected to HPLC analysis using a Gemini column and gradient 
elution with UV detection. The chromatogram of Helopyrin tablets is shown in 
Fig. 7. The hesperidin peak appeared at a retention time of 13.74 min, as con-
firmed by comparison with the chromatogram of the standard substance and by 
checking the UV and mass spectra of the corresponding peak.  
The calibration graph was constructed using working standard solutions of 
hesperidin. The regression equation of the calibration line was:  
_____________________________________________________________________________________________________________________
2012 Copyright (CC) SCS
Available online at www.shd.org.rs/JSCS/
 FLUORIMETRIC DETERMINATION OF HESPERIDIN 1637 
 A = (4.83±0.05)×104c + (2.1±0.2)×103 (5) 
 (N = 10, r2 = 0.9998) 
where A is the area of the SRM transition and c is the sample concentration in μg 
mL–1. The linear range was 0.05–10.0 μg hesperidin mL–1. The LOD, calculated 
from the calibration line, was 0.01 μg mL–1 and the LOQ was 0.03 μg mL–1. 
Three aliquots of tablet solution were subjected to chromatographic analysis. The 
results of the analysis are given in Tables IV and V. 
 
Fig. 7. Chromatogram of the helopyrin tablets. 
TABLE IV. HPLC/UV Analysis of helopyrin tablets 
Taken, μg mL-1 Found, μg mL-1 Recovery, % SD CV / % 
1.5 1.26 84.00 0.25 0.17 
3.0 2.84 94.66 0.36 0.12 
6.0 5.75 95.83 0.39 0.07 
TABLE V. HPLC/UV Analysis of combined Vitamin C tablets for their hesperidin content 
Taken, μg mL-1 Found, μg mL-1 Recovery, % SD CV / % 
0.1 0.08 75.00 0.3 8.3 
0.2 0.2 88.00 0.7 3.65 
0.3 0.3 95.33 0.2 0.76 
Low recovery of determination of hesperidin in Vitamin C tablets could be 
explained by absorption of other substances present in tablets that absorb at the 
same wavelength as hesperidin and could not be removed by the SPE extraction. 
Analysis of plasma samples  
The mass spectrum consists of six signals of various intensities (Table VI). 
Intensity (peak area) of m/z 609 → 325 transition was followed. The cal-
culated equation of the calibration line was:  
 A = (4.83±0.02)×104c + (1.75±0.09)×103 (6) 
_____________________________________________________________________________________________________________________
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where A is the area of the SRM transition and c is the sample concentration in μg 
mL–1) for 10 samples. The linearity range was 0.02–10.0 μg mL–1. The LOD was 
estimated from n = 7 replicate measurements of the samples in the concentration 
range 0.002–0.05 μg mL–1 and n = 7 replicate measurements of the reagent blank 
(methanol). This procedure provided an LOD estimate of 5.0×10–3 μg mL–1, i.e., 
5.0 ng mL–1. The LOQ may then be taken as 15.0 ng mL–1. 
The results of analysis of spiked plasma samples are presented in Table VII, 
from which the excellent recovery can be seen; thus, indicating the good 
accuracy of the method. 
TABLE VII. Accuracy and precision of the HPLC/MS analysis of serum samples spiked with 
hesperidin (N = 5) 
Taken, μg mL-1 Found, μg mL-1 Recovery, % SD CV / % 
0.5 0.497 99.4 0.006 1.21 
1.0 1.02 102.0 0.06 5.88 
2.5 2.48 99.2 0.05 2.02 
5.0 5.19 102.0 0.03 0.58 
The good recovery for the determination hesperidin with the serum sample 
could be explain by the facts that the LC–MS/MS detection method is much 
more sensitive and specific compared with the other method and the 
concentration level was 10 to 100 times higher than in the serum examined by 
HPLC. This concentration range was used because it is the optimal concentration 
in human serum after oral dosage of tablets containing hesperidin.30  
CONCLUSIONS 
In this work, a simple, precise and accurate method for the determination of 
hesperidin in human plasma and tablets based on the fluorescence properties of 
the aluminium–complex in micellar media was developed. The reliability of the 
method was confirmed by parallel determination of hesperidin in human plasma 
using mass spectrometry while the determinations of hesperidin in tablets were 
compared with an HPLC/UV determination using gradient elution. The fluoro-
metric determination of hesperidin in human plasma, after its complexation with 
TABLE VI. Mass spectrum of hesperidin 
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aluminium(III)-ion, provides good accuracy and precision and may be used for 
routine clinical analysis, since it is considerably simpler and less time consuming 
than mass spectrometric determinations. The fluorometric determination in do-
sage forms may be successful only when no other flavonoids which bind alu-
minium to adjacent 3-hydroxy and 4-keto groups (stoichiometry 1:1) are present. 
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И З В О Д  
РАЗВОЈ И ВАЛИДАЦИЈА ФЛУОРИМЕТРИЈСКЕ МЕТОДЕ ЗА ОДРЕЂИВАЊЕ 
ХЕСПЕРИДИНА У ХУМАНОМ СЕРУМУ И ФАРМАЦЕУТСКИМ ПРЕПАРАТИМА 
ЛЕПОСАВА А. ПАВУН1, ЈАСМИНА М. ДИМИТРИЋ МАРКОВИЋ2, ПРЕДРАГ Т. ЂУРЂЕВИЋ3, МИЛЕНА Д. 
ЈЕЛИКИЋ СТАНКОВ4, ДАНИЕЛА Б. ЂИКАНОВИЋ5, АНДРИЈА Р. ЋИРИЋ3 и ДУШАН Л. МАЛЕШЕВ1 
1Катедра за физичку хемију и инструменталне методе, Фармацеутски факултет, Универзитет у 
Београду, Војводе Степе 450, 11000 Београд, 2Факултет за за физичку хемију, Универзитет у 
Београду, Студентски трг 12, 11000 Београд, 3Институт за хемију, Природно–математички 
факултет, Универзитет у Крагујевцу, Радоја Домановића 12, 34000 Крагујевац, 4Катедра за 
аналитичку хемију, Фармацеутски факултет, Универзитет у Београду, Војводе Степе 450, 
11000 Београд и 5Институт за мултидисциплинарна истраживања, Универзитет у Београду, 
Деспота Стефана 142, 11000 Београд 
Развијена је флуориметријска метода за одређивање хесперидина у хуманом се-
руму и фармацеутским препаратима која се заснива на флуoресценцији комплекса алу-
минијум(III)–хесперидин. Комплекс показује интензивну флуоресценцију у присуству 
сурфактанта SB 12 на 476 nm приликом ексцитације на 390 nm. Линеарна зависност ин-
тензитета флуоресценције од концентрације при одређивању хесперидина у фармацеут-
ским препаратима добијена је у концентрационом опсегу 0,06–24,4 μg mL-1 са границом 
детекције од 0,016 μg mL-1 и границом квантификације од 0,049 μg mL-1. Добијене 
„recovery“ вредности у интервалу 99,3–99,7 % показују велику прецизност методе. Ли-
неарна зависност интензитета флуоресценције компекса од концентације хесперидина 
добијена је у концентрационом опсегу 0,1–12,2 μg mL-1 са границом детекције од 0,032 
μg mL-1 и границом квантификације од 0,096 μg mL-1. „Recovery“ вредности су добијене у 
опсегу 98,4 до 99,8 %. Поузданост методе проверена је LC–MS/MS методом за одређи-
вањe хесперидина у серуму, а HPLC/UV методом проверена је поузданост приликом од-
ређивања хесперидина у фармацеутским препаратима. Линеарна зависност при одре-
ђивању хесперидина у фармацеутским препаратима добијена је у интервалу 0,05–10,00 
μg mL-1. Граница детекције је износила 0,01, а граница квантификације је 0,03 μg mL-1. 
Линеарна зависност при одређивању хесперидина у хуманом серуму је добијена у ин-
тервалу 0,02–10,00 μg mL-1 са границом детекције од 0,005 и границом квантификације 
од 0,015 μg mL-1. Добро слагање између ове две методе показује применљивост флуори-
метријске методе у клиничким лабораторијама и лабораторијама за контролу квалитета. 
Предложена флуoриметријска метода је једноставна, поуздана и прецизна за одређи-
вање хесперидина у хуманом серуму и фармацеутским препаратима. 
(Примљенo 5. октобра 2011, ревидирано 17. априла 2012) 
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